Skip to main content
Clinical Trials/CTRI/2021/02/031018
CTRI/2021/02/031018
Not yet recruiting
Phase 3

â??AN EXPLORATORY STUDY ON EFFECTIVENESS OF INDIVIDUALIZEDHOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF PHOBIC ANXIETYDISORDERS.â??

Dr AKHILA A0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: F40- Phobic anxiety disorders
Sponsor
Dr AKHILA A
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr AKHILA A

Eligibility Criteria

Inclusion Criteria

  • Cases satisfying PAD diagnostic criteria of ICD 10 DCR.
  • Age group between 18 to 60 years.

Exclusion Criteria

  • PAD with other psychiatric comorbidity.
  • Subjects who used psychotropic medicines in the past two weeks.
  • Subjects who are pregnant or lactating.
  • Severe systemic illness using conventional treatment.
  • Substance induced disorders.
  • Immuno\-compromised conditions like HIV, Tuberculosisetc.

Outcomes

Primary Outcomes

Not specified

Similar Trials